Evidence map›Paper›PMID 40111318›Full record

ArticleJAMA oncology2025

Accelerated Aging in Survivors of Childhood Cancer-Early Onset and Excess Risk of Chronic Conditions.

Jennifer M Yeh, Zachary J Ward, Kayla L Stratton, Mercedes V McMahon, Chelsea S Taylor, Gregory T Armstrong, Eric J Chow, Melissa M Hudson, Lindsay M Morton, Kevin C Oeffinger and 2 more

Abstract read
In one paragraph

Article in JAMA oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Skeletal muscle health in childhood cancer survivors: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Childhood cancer and future cardiometabolic health.npj metabolic health and disease · 2026
    Review
  3. Subsequent malignant neoplasm among cancer survivors in the United States.Journal of cancer survivorship : research and practice · 2026
    Article
  4. Review
  5. Article
  6. Hematopoietic stem cell transplantation-associated partial lipodystrophy.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Review
  7. Article
  8. Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Paediatric Endocrinology: Before and Beyond 'Ringing the Bell'.Journal of paediatrics and child health · 2025
    Article
  15. Cancer statistics, 2026.CA: a cancer journal for clinicians
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Jennifer M YehBoston Children's Hospital, Boston, Massachusetts.
Zachary J WardHarvard T.H. Chan School of Public Health, Boston, Massachusetts.
Kayla L StrattonFred Hutchinson Cancer Center, Seattle, Washington.
Mercedes V McMahonBoston Children's Hospital, Boston, Massachusetts.
Chelsea S TaylorBoston Children's Hospital, Boston, Massachusetts.
Gregory T ArmstrongSt Jude Children's Research Hospital, Memphis, Tennessee.
Eric J ChowFred Hutchinson Cancer Center, Seattle, Washington.
Melissa M HudsonSt Jude Children's Research Hospital, Memphis, Tennessee.
Lindsay M MortonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Kevin C OeffingerDuke University, Durham, North Carolina.
Lisa R DillerHarvard Medical School, Boston, Massachusetts.
Wendy M LeisenringFred Hutchinson Cancer Center, Seattle, Washington.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Mach-LETSGO: Machine-LEarning of Treatment, Survey, and Genetics towards Obtaining Correct Classification of Chronic Conditions in Adult Survivors in the Childhood Cancer Survivor Study - CCSS SupplU24CA055727 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Gregory Armstrong · 1999 to 2026
$96.7M
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the futureR01CA227576 · NCI · BOSTON CHILDREN'S HOSPITAL · PI YEH, JENNIFER M. · 2018 to 2022
$2.1M
NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA227576NCI NIH HHS U24 CA055727
6 · The paper itself

Abstract

Importance: The lifetime risk of aging-related diseases among survivors of childhood cancer, accelerated by cancer treatment exposures, is unknown. Understanding this risk can provide a more comprehensive assessment of long-term health across the lifespan of survivors and guide adult care. Objective: To estimate the lifetime risks of 8 treatment-related cancers and cardiovascular conditions among childhood cancer survivors and compare them with the general population. Design, Setting, Participants: Using data from the Childhood Cancer Survivor Study and national databases, this simulation modeling study projected long-term outcomes for 5-year survivors diagnosed between 1970 and 1999 based on treatment exposures and age-related risks. The general population comparator was simulated using age-, sex-, and calendar year-matched individuals who faced only age-related risks. Exposures: Treatment era (1970s, 1980s, 1990s), original cancer diagnosis, radiation treatment for primary diagnosis (any, none). Main Outcomes and Measures: Estimated lifetime risks of 8 health conditions (breast cancer, colorectal cancer, glial tumors, sarcomas, heart failure, coronary heart disease/myocardial infarction, stroke, and valvular disease). Risks were projected and compared with the general population, stratified by radiation exposure. Results: In the general population, 20% developed at least 1 health condition by age 65.0 years; in 5-year survivors this threshold was reached at age 47.3 years, representing a 17.7-year (95% uncertainty interval [UI], 14.0-21.0) acceleration in disease onset. By age 65 years, 55% of survivors were projected to develop at least 1 condition, indicating a 2.7-fold (95% UI, 2.2-3.5) higher relative risk and 34.2% (95% UI, 28.3-42.5) absolute excess risk compared with the general population. Risks were higher among those treated with radiation therapy for childhood cancer (22.0 years earlier onset [95% UI, 18.0-25.0]; 37.3% excess risk [95% UI, 31.6%-44.7%]) but still elevated for those without radiation exposure (13.5 years earlier onset [95% UI, 10.0-16.0]; 31.0% excess risk [95% UI, 23.9%-40.3%]). Reaching middle age was still associated with increased health risks. Compared with the general population, survivors who reached age 40 years had a 6.2-fold higher risk (95% UI, 4.8-9.4) of developing a new condition within 10 years. Conclusions and Relevance: This study found that survivors of childhood cancer experience accelerated onset of aging-related diseases, regardless of prior radiation exposure. These findings underscore the importance of prioritizing cancer and cardiovascular disease prevention among survivors decades earlier than for the general population.

Indexed as

Aging, PrematureCancer SurvivorsCardiovascular DiseasesNeoplasmsSurvivorsAdolescentAdultAgedAge of OnsetChildChild, PreschoolChronic DiseaseFemaleHumansInfantMale

Identifiers

PMID40111318
PMCPMC11926734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.